Taylor Clark
Primary Care · Greenville, SCNPI 1952008351
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 29.2% of the total.
Across 87 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$415
- Mayne Pharma Commercial LLC$205
- Sage Therapeutics, LLC$179
- Scilex Pharmaceuticals Inc.$109
- AbbVie$98
- Millicent US Inc$91
- plus $322 from 10 others
What the payments were for
- Food & beverage$1,419100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $415 |
| Mayne Pharma Commercial LLC | 20 | $205 |
| Sage Therapeutics, LLC | 8 | $179 |
| Scilex Pharmaceuticals Inc. | 5 | $109 |
| AbbVie | 5 | $98 |
| Millicent US Inc | 4 | $91 |
| Forte Bio-pharma LLC | 5 | $87 |
| Shield Therapeutics Inc | 3 | $59 |
| Organon | 3 | $42 |
| Daiichi Sankyo Inc. | 2 | $39 |
| Novo Nordisk | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| IBSA Pharma Inc. | 1 | $15 |
| Pfizer | 1 | $13 |
| Channel Medsystems, Inc. | 1 | $10 |
How this compares
$1,419 in reported general payments places this provider in the 65th percentile of 115 primary care providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 83 | $874 |
| Tizanidine Hcl | 53 | $425 |
| Celecoxib | 26 | $216 |
| Cyclobenzaprine Hcl | 36 | $194 |
| Diclofenac Sodium | 12 | $164 |
| Ibuprofen | 14 | $143 |
| Baclofen | 18 | $104 |
| Omeprazole | 11 | $69 |
| Meloxicam | 21 | $33 |
Paid to pharmacies, not to this prescriber.
Other primary care in Greenville
- Sarah TomashefskiGreenville$23K
- Amanda GroomeGreenville$9K
- Samantha VaughtNorth Myrtle Beach$15K
- Cynthia SmithSeneca$10K
- William ByrdSumter$10K
- Kathleen BoonePawleys Island$9K
- Holly SurrencyAiken$8K
- Jessica BoldenAnderson$8K
- Caren ArnetteDillon$7K
- Heather MartinSeneca$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.